Literature DB >> 17296365

Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.

John P Stein1, David F Penson, Jie Cai, Gus Miranda, Eila C Skinner, Matt A Dunn, Susan Groshen, Gary Lieskovsky, Donald G Skinner.   

Abstract

PURPOSE: To provide future mapping analysis of lymph node positive disease we modified our lymphadenectomy at radical cystectomy for bladder cancer from an en bloc packet to 13 separate nodal packets. We evaluated the clinical and pathological findings resulting from this modification.
MATERIALS AND METHODS: A total of 1,359 patients underwent en bloc radical cystectomy and extended lymphadenectomy for bladder cancer. They were compared to 262 patients who underwent radical cystectomy and extended lymphadenectomy with lymph nodes submitted in 13 distinct nodal packets. Overall 317 patients (23%) of the en bloc group (group 1) and 66 of the 262 (25%) in the separately packaged group (group 2) had node positive disease. Clinical and pathological findings were analyzed to compare these 2 groups of patients.
RESULTS: Although the incidence of lymph node positivity was not different, the median number of total lymph nodes removed in group 2 was significantly higher than that in group 1 (68, range 14 to 132 vs 31, range 1 to 96, p<0.001). A trend toward more lymph nodes involved was observed in group 2 compared to group 1 (3, range 1 to 91 vs 2, range 1 to 63, p=0.062). These findings significantly lowered median lymph node density in group 2 compared to that in group 1 (6% vs 9%, p=0.006).
CONCLUSIONS: Although the overall incidence of lymph node positive disease was not different, the submission of 13 separate nodal packets at radical cystectomy significantly increased the total number of lymph nodes removed/analyzed and identified a slightly higher number of positive lymph nodes compared to en bloc submission.

Entities:  

Mesh:

Year:  2007        PMID: 17296365     DOI: 10.1016/j.juro.2006.10.043

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

1.  Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.

Authors:  Douglas A Mata; Susan Groshen; Friedrich-Carl Von Rundstedt; Donald G Skinner; Walter M Stadler; Richard J Cote; John P Stein; Seth P Lerner
Journal:  J Surg Oncol       Date:  2015-04-14       Impact factor: 3.454

2.  Bladder cancer: narrowing the gap between evidence and practice.

Authors:  Maha H A Hussain; David P Wood; Dean F Bajorin; Bernard H Bochner; Robert Dreicer; Donald L Lamm; Michael A O'Donnell; Arlene O Siefker-Radtke; Dan Theodorescu; Colin P Dinney
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

3.  The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.

Authors:  Brett S Carver; Angel M Cronin; Scott Eggener; Caroline J Savage; Robert J Motzer; Dean Bajorin; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2010-03-17       Impact factor: 2.649

Review 4.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

Review 5.  The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?

Authors:  Karim Bensalah; Morgan Roupret; Evanguelos Xylinas; Shahrokh Shariat
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

6.  Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.

Authors:  Mahir Maruf; Abhinav Sidana; Stephanie Purnell; Amit L Jain; Sam J Brancato; Piyush K Agarwal
Journal:  Int Urol Nephrol       Date:  2017-12-23       Impact factor: 2.370

Review 7.  [Lymphadenectomy for bladder cancer: current status and controversies].

Authors:  T Metzger; G N Thalmann; P Zehnder
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

8.  Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis.

Authors:  Michael Ahdoot; Leanne Almario; Hiwot Araya; Jonas Busch; Simon Conti; Mark L Gonzalgo
Journal:  World J Urol       Date:  2014-01-28       Impact factor: 4.226

9.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

Review 10.  [Cystectomy in the elderly patient].

Authors:  G Bartsch; K Gust; S Vallo; C Bartsch; I Tsaur; J Mani; A Haferkamp
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.